 |
|
3 Steps
Maximum: 2 CME cr.
0 new discussion posts (3 published)
Sign in to view your progression
|
Program Overview
Progr...
Learning Objectives
Learn...
Target Audience
Targe...
Credit Designation
Credi...
Disclosure/Disclaimer
Discl...
Components
• The accredited activity contains the following modules to be completed:
- Pre-test
- Presentation
- Post-test
- Evaluation Form
• The accredited activity contains the following modules to be completed:
- Pre-test
- Presentation
- Post-test
- Evaluation Form
- Identify the key molecular markers necessary to select treatment in primary breast cancer
- Determine the various treatment options in primary breast cancer
- Identify the accepted molecular subtypes of breast cancer
- Estimate the benefit from various therapeutic interventions
Target Audience
Health care professionals with an interest in Breast Cancer.
Health care professionals with an interest in Breast Cancer.
CME Credit Designation
MULTILEARNING designates this enduring activity for a maximum of 2 CME credits.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Dr. Gabriel N. Hortobagyi
Houston, United States of America
Disclosure: Grant or research support from Novartis
Scientific advisory board member of Targeted Molecular Diagnostics
Houston, United States of America
Disclosure: Grant or research support from Novartis
Scientific advisory board member of Targeted Molecular Diagnostics
|
First step:"Self needs-assessment questions"
|
|
|
Selection of Optimal Treatment for Primary Breast Cancer Based on Molecular Markers
|
|
|
Evaluation Form & CME Certificate
|
|
{{ help_message }}
{{filter}}